GENE ONLINE|News &
Opinion
Blog

Nasal Spray
The First-Ever Nasal Spray for Anaphylactic Shock Gets FDA Approval
2024-08-12
Vistagen’s Positive Phase 3 Results for Social Anxiety Treatment
2023-08-10
Emergent BioSolutions’ Over-The-Counter Naloxone Nasal Spray Receives FDA Greenlight
2023-03-30
Pfizer’s Fast-Acting Migraine Nasal Spray Takes Home US Approval
2023-03-13
First Nasal Spray for Allergies Now Available Over-the-Counter
2022-07-13
Google-Backed Leyden Labs Closes $140 Million Series B to Fight Viruses with Nasal Spray
2022-01-26
Oyster Point’s Nasal Spray for Dry Eyes Notches FDA Approval
2021-10-19
VistaGen’s Antidepressant Nasal Spray Succeeds Phase 2a Trial
2020-02-22
LATEST
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
Health Secretary Kennedy Retracts Parts of Agency Reorganization Plan During Combative Congressional Hearing
2025-05-14
SURMOUNT-5 Trial: Zepbound Shows Greater Weight Loss Than Wegovy
2025-05-14
ASCGT Meeting Navigates Biotech Downturn After Multi-Year Slump
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top